Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Industry:
Biotechnology, Health Care, Science and Engineering
Technology:
Geroscience
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Investors Number:
1
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Employee Number:
101-250
Investor Type:
For Profit
Total Funding:
$5M
Founded Date:
1-1
Last Funding Type:
Private Equity